REQUEST A DEMO
Total
USD $0.00
Search more companies

Nellex Polska Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Merchant Wholesalers, Durable Goods | Retail Trade | Warehousing and Storage | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Research and Development in the Social Sciences and Humanities
Full name: Nellex Polska Sp. z o.o. Profile Updated: November 10, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Nellex Polska Sp. z o.o. is a company in Poland, with a head office in Warsaw. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on November 08, 2017. From the latest financial highlights, Nellex Polska Sp. z o.o. reported a net sales revenue drop of 5.28% in 2020. A growth of 14.04% was recorded in its total assets. The net profit margin of Nellex Polska Sp. z o.o. increased by 5.54% in 2020.

Headquarters
Warszawa
Warsaw; Mazowieckie; Postal Code: 02-305

Contact Details: Purchase the Nellex Polska Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nellex Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Nellex Polska Sp. z o.o. report to view the information.
Incorporation Date:
November 08, 2017
Key Executives
Company Performance
Financial values in the chart are available after Nellex Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-5.28%
Total operating revenue
-3.66%
Operating profit (EBIT)
12.96%
Net Profit (Loss) for the Period
27.46%
Total assets
14.04%
Total equity
119.46%
Operating Profit Margin (ROS)
3.88%
Net Profit Margin
5.54%
Return on Equity (ROE)
-35.68%
Debt to Equity Ratio
-91.84%
Quick Ratio
1.11%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?